Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company developing oral thin film drug delivery technologies, today announced the initiation ...
TechForce Robotics contributes to this evolution by embedding AI-driven SOP intelligence and real-time monitoring into its robotic systems. This enables compliance to function as an integrated, ...
As geopolitics bring reshoring interest to a fever pitch, the United States Pharmacopeia (USP) is adding to the impetus for ...
“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...
The FDA began accepting requests Feb. 1 to participate in its PreCheck pilot program, an initiative aimed at streamlining regulatory review for new U.S.-based pharmaceutical manufacturing facilities.
Opinion
6dOpinion
New I-MAK report documents how drug manufacturers extend monopoly pricing — costing Medicare and patients billions
Case studies of blockbuster drugs reveal a repeatable playbook of patent strategies that delay competition well beyond ...
Trump's order seeks to ease regulations to compel more U.S. drug manufacturing. He also plans to assess tariffs on drug ...
Drug price watchdogs worry President Donald Trump's plan to assess 100% tariffs on drug imports could lighten patients ...
In the opening remarks, Michael Kopcha, Director of the Office of Pharmaceutical Quality (OPQ), offered CDER’s perspective on advanced manufacturing and pharmaceutical quality. He began the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results